#Trials

Kert Viele

KertViele

(1/n) We often see related datasets (multiple vaccine trials, multiple trials exploring the amyloid hypothesis in Alzheimer’s, basket trials in oncology) How do we think about multiple groups of data

Andrew Wortman 🏳️‍🌈

AmoneyResists

Since @LindseyGrahamSC seems hellbent on redefining hypocrisy to protect Trump, let’s look back on what this man used to claim to believe about impeachment, SCOTUS appointments, witnesses at impeachment trials,

Dr Nicole E Basta

IDEpiPhD

As you consider the #COVID19 #vaccine debates about 1 vs 2 doses, timing of 2nd dose & dosing w/ 2 diff vaccines, keep in mind there is no "right" answer

Anant Bhan

AnantBhan

This is a letter which has been sent out by the ICMR DG yesterday. Now that multiple folks have confirmed genuineness, let me raise some issues with this letter on

Saurabh Joglekar (सौरभ जोगळेकर)

joglekarsaurabh

#Pune has a proven track record of high quality standards in education & ease of living; with culture, heritage & traditions intact. Pune has responded to this Pandemic situation like no

Rupert Pearse

rupert_pearse

Some interesting news here from @remap_cap that #Tocilizumab may improve patient outcomes for COVID-19. Understandable that the team are eager to announce this but given the limited detail and small

Avon Healthcare

AVONHMO

"Vaccine production usually takes years so how come #COVID19 vaccines were ready within one year? Are you sure they would be safe?"We'll give you 10 reasons Covid-19 vaccines arrived on

Peter Black

pcvblack

Still digesting #bladdercancer trials at #GU21. QUILT 3.032 trial https://clinicaltrials.gov/ct2/show/NCT03022825 testing #N803 in BCG-unresponsive CIS was an important result. Safety data appropriate for intravesical therapy – and CR rat

Hydroxychloroquine Works #HCQworks

_JulietJohnson

MORE CASESTests have been found to be inaccurate and show a high false positive rate.More tests being done than before. More tests gives more 'postives'.Also winter flu season has started

G Kang

GKangInd

A thread on vaccine safety, adverse events following immunization (AEFI) and assessments that happen when vaccines are tested before licensure. WHO has a great course at https://vaccine-safety-training.org/home.html from which a

Kenneth Rockwood

Krockdoc

Great question. Most key trials preceded the Clinical Frailty Scale. @GrahamEllis247 will know best, but here’s my read. (A 7-part thread; forgive me.) Back in the late ‘70s (when I

Adam W Gaffney

awgaffney

This is absolutely the right call, but it makes me so livid. We could know today whether plasma saves lives, does nothing, or makes things worse. But we elected to

Alasdair Munro

apsmunro

I have the great privilege of working on the Oxford #COVID19 vaccine trialsSafety is the top concern in all vaccine trials, and we go to great lengths to ensure the

Natalie E. Dean, PhD

nataliexdean

Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low dose recipients "received their second dose after a substantial gap." Only

Mr. & Mrs. Fred Fredderson

FredFredderson1

“Our trial will not demonstrate prevention of transmission, because in order to do that you have to swab people twice a week for very long periods, and that becomes operationally

A.D. Quig

ad_quig

CDPH's Dr. Arwady: Between 125,000 and 180,000 Chicagoans have active, infectious COVID right now. That's 1 in 15 Chicagoans. "That is why the risk of gathering is significant. It's why

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.